| 05/15/2026 12:12 PM | Cormorant Asset Management, LP (1583977) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 05/14/2026 9:30 AM | BML Investment Partners, L.P. (1373604) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 05/13/2026 8:23 PM | BML Investment Partners, L.P. (1373604) Filed by enGene (1980845) Subject | Form SCHEDULE 13G | |
| 05/08/2026 3:06 PM | enGene (1980845) Filer | Form DEF 14A | |
| 05/07/2026 6:11 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/05/2026 9:59 AM | enGene (1980845) Subject Invus Global Management, LLC (2005369) Filed by | Form SCHEDULE 13G/A | |
| 04/09/2026 3:02 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/09/2026 11:20 AM | enGene (1980845) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/09/2026 6:25 AM | enGene (1980845) Filer | Form 424B5 | |
| 03/09/2026 6:09 AM | enGene (1980845) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 03/09/2026 6:15 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for ENGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for enGene and its competitors with MarketBeat's FREE daily newsletter.
|
| 03/09/2026 6:04 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/02/2026 11:15 PM | enGene (1980845) Filer | Form EFFECT | |
| 02/19/2026 3:25 PM | enGene (1980845) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 02/17/2026 5:09 PM | enGene (1980845) Subject Venrock Healthcare Capital Partners III, L.P. (1738048) Filed by | Form SCHEDULE 13G/A | |
| 02/17/2026 2:00 PM | Cormorant Asset Management, LP (1583977) Filed by enGene (1980845) Subject | Form SCHEDULE 13G | |
| 02/17/2026 11:46 AM | enGene (1980845) Subject Kynam Capital Management, LP (1907884) Filed by | Form SCHEDULE 13G/A | |
| 01/27/2026 1:18 PM | enGene (1980845) Subject Invus Global Management, LLC (2005369) Filed by | Form SCHEDULE 13G | |
| 01/21/2026 6:38 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/22/2025 3:11 PM | enGene (1980845) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 12/22/2025 3:04 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 7:12 AM | Deep Track Capital, LP (1856083) Filed by enGene (1980845) Subject | Form SCHEDULE 13G/A | |
| 11/14/2025 6:01 AM | enGene (1980845) Filer | Form 424B5 | |
| 11/12/2025 5:16 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/30/2025 6:36 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/11/2025 3:44 PM | enGene (1980845) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 09/11/2025 3:08 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/11/2025 3:11 PM | enGene (1980845) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 09/03/2025 6:56 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/14/2025 3:09 PM | Boyd Matthew Ross (2077001) Reporting enGene (1980845) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/14/2025 3:10 PM | Boyd Matthew Ross (2077001) Reporting enGene (1980845) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/08/2025 3:10 PM | enGene (1980845) Issuer Grossman William (1730229) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 07/08/2025 3:11 PM | Astley-Sparke Philip (1376491) Reporting enGene (1980845) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/08/2025 3:13 PM | enGene (1980845) Issuer Heffernan Michael Thomas (1448914) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 07/08/2025 3:08 PM | Buck Jill (1780426) Reporting enGene (1980845) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/08/2025 7:09 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/16/2025 5:36 PM | Bos Jasper (1897789) Reporting enGene (1980845) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 5:37 PM | BRUNK GERALD A (1380226) Reporting enGene (1980845) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 5:38 PM | enGene (1980845) Issuer Glickman Richard M (1352637) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 5:38 PM | enGene (1980845) Issuer HASTINGS PAUL J (1309702) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 5:39 PM | enGene (1980845) Issuer Joustra Wouter (1897813) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Your $29.97 book is free today (Ad) Why Some Traders Skip Stocks Entirely
You don't need a big account to trade options.
In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up.
This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account. Normally $29.97. Today it's free. Grab your copy now. |
| 06/16/2025 5:40 PM | enGene (1980845) Issuer Pott Amy (1787363) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 5:40 PM | enGene (1980845) Issuer Zoth Lota S. (1278219) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 7:05 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/12/2025 7:08 AM | enGene (1980845) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 06/10/2025 4:26 PM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/09/2025 6:29 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/04/2025 7:35 AM | enGene (1980845) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/29/2025 4:30 PM | enGene (1980845) Issuer Pott Amy (1787363) Reporting | Form 3 Initial statement of beneficial ownership of securities | |